Want to see JP:7813 full AI Analyst Report?
7813 Stock Chart & Stats
¥839.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥839.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥659.00 - ¥977.00
Previous CloseN/A
Volume8.60K
Average Volume (3M)4.70K
Market Cap
¥2.90B
Enterprise Value¥3.84B
Total Cash (Recent Filing)¥1.57B
Total Debt (Recent Filing)¥2.18B
Price to Earnings (P/E)11.6
Beta0.31
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.21%
Share Statistics
EPS (TTM)71.06
Shares Outstanding3,726,000
10 Day Avg. Volume4,840
30 Day Avg. Volume4,703
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)0.80
Price to Sales (P/S)0.29
P/FCF Ratio620.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability GrowthSustained double-digit revenue growth with improving net margins indicates the business is expanding product uptake and managing costs. Over a multi-month horizon this supports reinvestment in product development and distribution, strengthening competitive position in medical equipment markets.
Stable Balance Sheet / Manageable LeverageAn improving leverage profile and stable equity ratio provide financial flexibility for cyclical procurement patterns in healthcare. Manageable debt reduces refinancing risk and supports steady capital allocation to R&D, inventory, or targeted M&A over the next several months.
Improved Free Cash Flow ConversionRising free cash flow and strong conversion versus net income enhance internal funding capacity for capex, product upgrades and shareholder returns. Durable FCF performance reduces reliance on external financing and bolsters the firm's ability to execute medium-term strategic initiatives.
Bears Say
Decreasing Operating Cash FlowA drop in operating cash flow signals potential working-capital strain or timing mismatches in receipts and payables. Over several months this can constrain liquidity for day-to-day operations, limit flexibility in procurement cycles and force heavier reliance on cash reserves or external financing.
Low EBIT Margin / Operational Efficiency GapA relatively low EBIT margin reduces the company's cushion against cost shocks and limits reinvestment capacity. Persisting margin pressure implies structural inefficiencies or scale limits that must be addressed to sustain profit growth and competitiveness over the medium term.
Concentration In Hospital And Care Bed ProductsHeavy dependence on hospital and long-term care bed sales concentrates revenue risk to procurement cycles, budget timing and regulation in healthcare institutions. Limited product diversification can amplify demand swings and slows secular revenue resilience over a 2-6 month horizon.
PLATZ Co., Ltd. News
7813 FAQ
What was PLATZ Co., Ltd.’s price range in the past 12 months?
PLATZ Co., Ltd. lowest stock price was ¥659.00 and its highest was ¥977.00 in the past 12 months.
What is PLATZ Co., Ltd.’s market cap?
PLATZ Co., Ltd.’s market cap is ¥2.90B.
When is PLATZ Co., Ltd.’s upcoming earnings report date?
PLATZ Co., Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 21 days.
How were PLATZ Co., Ltd.’s earnings last quarter?
PLATZ Co., Ltd. released its earnings results on May 14, 2026. The company reported ¥43.26 earnings per share for the quarter, beating the consensus estimate of N/A by ¥43.26.
Is PLATZ Co., Ltd. overvalued?
According to Wall Street analysts PLATZ Co., Ltd.’s price is currently Overvalued.
Does PLATZ Co., Ltd. pay dividends?
PLATZ Co., Ltd. pays a Annually dividend of ¥24 which represents an annual dividend yield of 2.21%. See more information on PLATZ Co., Ltd. dividends here
What is PLATZ Co., Ltd.’s EPS estimate?
PLATZ Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PLATZ Co., Ltd. have?
PLATZ Co., Ltd. has 3,726,000 shares outstanding.
What happened to PLATZ Co., Ltd.’s price movement after its last earnings report?
PLATZ Co., Ltd. reported an EPS of ¥43.26 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PLATZ Co., Ltd.?
Currently, no hedge funds are holding shares in JP:7813
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PLATZ Co., Ltd.
Platz Co., Ltd. is a Japanese manufacturer and distributor specializing in care beds, mattresses, and related equipment. Its product range features beds specifically designed for nursing care, hospitals, and other care facilities, alongside adjustable reclining beds and various accessories. The company serves a client base that includes medical device and nursing care product retailers, as well as furniture stores. Founded in 1992 in Onojo, Japan, the company was originally known as Kyushu Waken ltd. until it adopted the name Platz Co., Ltd. in June 1995.
Technical Analysis
JINS HOLDINGS
―
Menicon Co
―
Japan Eyewear Holdings Co.,Ltd.
―
Seed Co., Ltd.
―
Shofu Inc.
―